Moriarty John B
SEC-identified person · CIK 1564621 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Kardigan, Inc. KARD | Chief Legal Officer | filed 2026 - 2026 |
| Avidity Biosciences, Inc. RNAM | Chief Legal Officer | filed 2024 - 2026 |
| Mirati Therapeutics, Inc. mrtx | Chief Legal Officer | filed 2023 - 2024 |
| Olema Pharmaceuticals, Inc. OLMA | EVP, Ch. Legal Officer & Sec. | filed 2020 - 2023 |
| Portola Pharmaceuticals INC PTLA | EVP, General Counsel | filed 2018 - 2020 |
| Alexion Pharmaceuticals, INC. alxn | SVP & General Counsel | filed 2012 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.